Interpretable XGBoost-SHAP model predicts short-term recurrence after first-episode acute pancreatitis

可解释的 XGBoost-SHAP 模型预测首次急性胰腺炎发作后的短期复发

阅读:1

Abstract

OBJECTIVE: To construct an eXtreme Gradient Boosting (XGBoost) model for predicting short-term recurrence after first-episode acute pancreatitis (AP) and employ SHapley Additive exPlanations (SHAP) analysis for feature interpretation. METHODS: A total of 442 patients with first-episode AP admitted to Cangzhou Central Hospital from October 2018 to June 2023 were retrospectively analyzed. The short-term recurrence was defined as a second attack after first-episode AP within 1 year. The cohort was split randomly, with 70% of the patients (n = 321) used for model training and 30% (n = 121) reserved for validation. Cox regression analysis was employed to identify independent predictors affecting recurrence, and an XGBoost model was constructed based on predictors. The XGBoost model was assessed by using area under the curve (AUC), calibration curve, decision curve analysis (DCA), and SHAP analysis. RESULTS: Three features were determined as predictors of recurrence. They included elevated triglycerides, alcohol drinking, and pancreatic necrosis. The XGBoost model demonstrated favorable performance, achieving an AUC of 0.933 (95% CI: 0.895-0.970) in the training cohort and of 0.874 (95% CI: 0.777-0.970) in the validation cohort. The calibration curve exhibited strong consistency between the anticipated and observed values, and DCA confirmed that the XGBoost model provided great clinical benefit. SHAP analysis also proved that elevated triglycerides, alcohol drinking, and pancreatic necrosis were decisive for the effect of the XGBoost model. CONCLUSION: The XGBoost model can accurately predict short-term recurrence. The SHAP approach can enhance the interpretability of the machine-learning model and support clinical decision-making.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。